Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?

Autor: Flora Zagouri, Grigorios Xepapadakis, George Pentheroudakis, Maria Sotiropoulou, Alexandra Papoudou-Bai, Helen Gogas, Christos Christodoulou, Christos Markopoulos, Helen P. Kourea, George C. Zografos, Georgia-Angeliki Koliou, Kalliopi Petraki, Niki Arnogiannaki, Triantafyllia Koletsa, Vassiliki Kotoula, Ioannis Kostopoulos, Konstantine T. Kalogeras, Kyriaki Manousou, Angelos Koutras, V. Venizelos, Dimitrios Bafaloukos, Alexandros Iliadis, Elissavet Pazarli, George Fountzilas, Sofia Chrisafi, Kyriakos Chatzopoulos
Rok vydání: 2019
Předmět:
Zdroj: Cancer immunology, immunotherapy : CII. 69(8)
ISSN: 1432-0851
Popis: Tumor-infiltrating lymphocytes (TILs) and their subsets contribute to breast cancer prognosis. We investigated the prognostic impact of CD3+, CD8+ and FOXP3+ TILs in patients with early intermediate/high-risk breast cancer treated with adjuvant anthracycline-based chemotherapy within two randomized trials conducted by our Group. We examined 1011 patients (median follow-up 130.9 months) and their tumors for total, stromal (s) and intratumoral (i) CD3, CD8 and FOXP3 lymphocyte density (counts/mm2) on tissue-microarray cores by immunohistochemistry. Morphological sTIL density on whole H&E-stained sections was also evaluated. The majority of TILs were CD3+. Total CD3 and CD8, sCD3 and sCD8, iCD3 and iCD8, sFOXP3 and iFOXP3 were strongly correlated (Spearman’s rho values > 0.6). High individual lymphocytic subsets and sTIL density were strongly associated with high tumor grade, higher proliferation and HER2-positive and triple-negative tumors (all p values
Databáze: OpenAIRE